Bridging Science and Diagnostics
Established in the mid-1970s, New England Biolabs (NEB) is a pioneering biotechnology company renowned globally for its premium-quality enzymes and reagents designed to advance molecular biology research. For over 50 years, scientists worldwide have relied on NEB’s cutting-edge solutions for their reliability, consistency, and innovation.
BioVendor R&D’s comprehensive and highly validated product portfolio includes:
Immunoassay & ELISA Kits: High-quality, sensitive ELISA kits specifically optimized for quantification of biomarkers related to cardiovascular disease, metabolic disorders, oncology, endocrinology, inflammation, autoimmunity, and infectious diseases, facilitating accurate diagnostics and translational research.
Monoclonal and Polyclonal Antibodies: Expertly developed and rigorously validated antibodies tailored for use in ELISA, Western blotting, immunohistochemistry, and other immunoassay-based techniques. These antibodies ensure exceptional specificity, sensitivity, and reproducibility.
Recombinant Proteins: Highly purified and biologically active recombinant proteins, growth factors, cytokines, enzymes, and antigens, widely used in research, assay development, and therapeutic investigations, enabling breakthroughs in biomedical research.
Molecular Diagnostics Solutions: Advanced PCR-based diagnostic test kits designed for precise detection of genetic variants, mutations, and infectious disease biomarkers, supporting accurate diagnostics and personalized patient management.
MicroRNA Profiling and Innovative Biomarkers: Cutting-edge biomarker assays and miRNA profiling solutions, allowing researchers to identify novel diagnostic and therapeutic targets critical for personalized medicine, oncology, and cardiovascular research.
Headquartered in Brno, Czech Republic, BioVendor R&D maintains world-class manufacturing facilities and rigorous quality standards (ISO 13485 certified), ensuring reliable performance and consistent product quality. With a strong emphasis on innovation, BioVendor continuously invests in R&D, driving advancements in biotechnology and diagnostics.
Committed to fostering scientific advancement, BioVendor collaborates extensively with academic institutions, healthcare providers, and biotech industries worldwide. This approach accelerates the translation of scientific discoveries into tangible diagnostic and therapeutic solutions, enhancing patient care and clinical outcomes globally.
Partnering with BioVendor R&D ensures access to highly reliable, innovative immunological and diagnostic solutions, empowering researchers and clinicians to effectively tackle current and future biomedical challenges.